title: [Fatal subfulminant hepatitis probably due to the combination benazepril-hydrochlorothiazide (Briazide)].
authors.forename: I
authors.initials: I
authors.lastname: Hourmand-Ollivier
authors.forename: S
authors.initials: S
authors.lastname: Dargere
authors.forename: D
authors.initials: D
authors.lastname: Cohen
authors.forename: M P
authors.initials: MP
authors.lastname: Galais
authors.forename: B
authors.initials: B
authors.lastname: Mosquet
authors.forename: P
authors.initials: P
authors.lastname: Rousselot
authors.forename: T
authors.initials: T
authors.lastname: Dao
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001552:Benzazepines / Q000008:administration & dosage / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D004338:Drug Combinations; D004347:Drug Interactions; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000959:Antihypertensive Agents; D001552:Benzazepines; D004338:Drug Combinations; D006852:Hydrochlorothiazide; C044946:benazepril